Autonomic neural regulation of immunity

The ‘cytokine theory of disease’ states that an overproduction of cytokines can cause the clinical manifestations of disease. Much effort has been expended to determine how cytokines are regulated in normal health. Transcriptional, translational and other molecular control mechanisms protect the host from excessive cytokine production. A recent discovery revealed an unexpected pathway that inhibits macrophage cytokine production. The inflammatory reflex is a physiological pathway in which the autonomic nervous system detects the presence of inflammatory stimuli and modulates cytokine production. Afferent signals to the brain are transmitted via the vagus nerve, which activates a reflex response that culminates in efferent vagus nerve signalling. Termed the ‘cholinergic anti‐inflammatory pathway’, efferent activity in the vagus nerve releases acetylcholine (ACh) in the vicinity of macrophages within the reticuloendothelial system. ACh can interact specifically with macrophage α7 subunits of nicotinic ACh receptors, leading to cellular deactivation and inhibition of cytokine release. This ‘hard‐wired’ connection between the nervous and immune systems can be harnessed therapeutically in animal models of inflammatory disease, via direct electrical stimulation of the vagus nerve, or through the use of cholinergic agonists that specifically activate the macrophage α7 subunit of the ACh receptor. Autonomic dysfunction has been associated with human inflammatory diseases including rheumatoid arthritis, diabetes and sepsis; whether this dysfunction results from the inflammatory component of these diseases, or is actually an underlying cause, is now less clear. The description of the cholinergic anti‐inflammatory now brings to the fore several new therapeutic strategies for inflammatory disease, and suggests that many of these diseases may actually be diseases of autonomic dysfunction.

[1]  L. Minutoli,et al.  Efferent Vagal Fibre Stimulation Blunts Nuclear Factor-&kgr;B Activation and Protects Against Hypovolemic Hemorrhagic Shock , 2003, Circulation.

[2]  P. Sawchenko,et al.  Evidence for an Intramedullary Prostaglandin-Dependent Mechanism in the Activation of Stress-Related Neuroendocrine Circuitry by Intravenous Interleukin-1 , 1997, The Journal of Neuroscience.

[3]  R J Sclabassi,et al.  Uncoupling and recoupling of autonomic regulation of the heart beat in pediatric septic shock. , 2001, Shock.

[4]  J. Schölmerich,et al.  Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn's disease and ulcerative colitis , 1997, Journal of Neuroimmunology.

[5]  K. Tracey,et al.  Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation , 2005, The Journal of experimental medicine.

[6]  M. Kluger,et al.  Nicotine-Induced Modulation of T Cell Function , 1998 .

[7]  W. Banks,et al.  Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier , 1994, Journal of Neuroimmunology.

[8]  Michael F. Wilson,et al.  Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. , 1990, Critical care medicine.

[9]  R. Lukas,et al.  Effects of Nicotine Exposure on T Cell Development in Fetal Thymus Organ Culture: Arrest of T Cell Maturation1 , 2002, The Journal of Immunology.

[10]  S. Rivest,et al.  Toll‐like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram‐negative bacterial cell wall components , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  K. Tracey,et al.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.

[12]  M. Parsons,et al.  Nicotinic acetylcholine receptor subunits and receptor activity in the epithelial cell line HT29. , 2003, Life sciences.

[13]  M. Herkenham,et al.  Area postrema removal abolishes stimulatory effects of intravenous interleukin-1β on hypothalamic-pituitary-adrenal axis activity and c-fos mRNA in the hypothalamic paraventricular nucleus , 1998, Brain Research Bulletin.

[14]  G. Bernard,et al.  Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. , 1999, Critical care medicine.

[15]  D. Rampton SMOKING AND ULCERATIVE COLITIS , 1984, The Lancet.

[16]  S. Ho,et al.  Peripheral neuropathy in systemic lupus erythematosus. , 1999, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[17]  H. Berthoud,et al.  Functional and chemical anatomy of the afferent vagal system , 2000, Autonomic Neuroscience.

[18]  K. Tracey,et al.  Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.

[19]  J. Blalock Shared Ligands and Receptors As a Molecular Mechanism for Communication between the Immune and Neuroendocrine Systems , 1994, Annals of the New York Academy of Sciences.

[20]  S. Maier,et al.  The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[21]  K. Tracey,et al.  Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation , 2000, Autonomic Neuroscience.

[22]  K. Kawashima,et al.  Extraneuronal cholinergic system in lymphocytes. , 2000, Pharmacology & therapeutics.

[23]  P. Sawchenko,et al.  Type 1 interleukin‐1 receptor in the rat brain: Distribution, regulation, and relationship to sites of IL‐1–induced cellular activation , 1995, The Journal of comparative neurology.

[24]  C. Brampton,et al.  An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease , 2000, Inflammation Research.

[25]  A. Weyrich,et al.  Engagement of P-selectin Glycoprotein Ligand-1 Enhances Tyrosine Phosphorylation and Activates Mitogen-activated Protein Kinases in Human Neutrophils* , 1997, The Journal of Biological Chemistry.

[26]  R. Eliakim,et al.  Divergent effects of nicotine administration on cytokine levels in rat small bowel mucosa, colonic mucosa, and blood. , 2003, The Israel Medical Association journal : IMAJ.

[27]  S. Simon,et al.  Neutrophil Tethering on E-Selectin Activates β2 Integrin Binding to ICAM-1 Through a Mitogen-Activated Protein Kinase Signal Transduction Pathway1 , 2000, The Journal of Immunology.

[28]  F. Dudek,et al.  Vagally evoked synaptic currents in the immature rat nucleus tractus solitarii in an intact in vitro preparation , 1998, The Journal of physiology.

[29]  M. Suarez‐Almazor,et al.  Autonomic dysfunction in patients with systemic lupus erythematosus. , 1998, The Journal of rheumatology.

[30]  R. Travagli,et al.  Brainstem pathways responsible for oesophageal control of gastric motility and tone in the rat , 1999, The Journal of physiology.

[31]  E. Tan,et al.  SYMPATHETIC SKIN RESPONSE AND R-R INTERVAL VARIATION IN RHEUMATOID ARTHRITIS: Two Simple Tests for the Assessment of Autonomic Function , 1993, American journal of physical medicine & rehabilitation.

[32]  G. Serratrice,et al.  Autonomic nervous system involvement in rheumatoid arthritis. 50 cases. , 1993, The Journal of rheumatology.

[33]  E. Wada,et al.  In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  K. Kubo,et al.  Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[35]  D. Altavilla,et al.  Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. , 2004, Cardiovascular research.

[36]  S. Maier,et al.  Vagal immune-to-brain communication: a visceral chemosensory pathway , 2000, Autonomic Neuroscience.

[37]  D. McTigue,et al.  Vagal control of digestion: Modulation by central neural and peripheral endocrine factors , 1996, Neuroscience & Biobehavioral Reviews.

[38]  M. Satoh,et al.  Localization of type I interleukin-1 receptor mRNA in the rat brain. , 1994, Brain research. Molecular brain research.

[39]  W. Banks,et al.  Murine tumor necrosis factor alpha is transported from blood to brain in the mouse , 1993, Journal of Neuroimmunology.

[40]  K. Tracey,et al.  Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. , 2002, Journal of vascular surgery.

[41]  K. Tracey,et al.  Is Severe Sepsis a Neuroendocrine Disease? , 2002, Molecular medicine.

[42]  A. Weindl,et al.  Peering through the Windows of the Brain , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  W. Banks,et al.  Blood–Brain Barrier Permeability to Ebiratide and TNF in Acute Spinal Cord Injury , 1997, Experimental Neurology.

[44]  K. Racké,et al.  Acetylcholine via muscarinic receptors inhibits histamine release from human isolated bronchi. , 1997, American journal of respiratory and critical care medicine.

[45]  H. Teede,et al.  Vascular dysfunction and autonomic neuropathy in Type 2 diabetes , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[46]  S. Rivest,et al.  Effect of Acute Systemic Inflammatory Response and Cytokines on the Transcription of the Genes Encoding Cyclooxygenase Enzymes (COX‐1 and COX‐2) in the Rat Brain , 1998, Journal of neurochemistry.

[47]  M. Kluger,et al.  Nicotine-induced modulation of T Cell function. Implications for inflammation and infection. , 1998, Advances in experimental medicine and biology.

[48]  P. Gross,et al.  Sensory circumventricular organs and brain homeostatic pathways , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  T B Kuo,et al.  Spectral analysis of systemic arterial pressure and heart rate signals as a prognostic tool for the prediction of patient outcome in the intensive care unit. , 1997, Critical care medicine.

[50]  A. Kastin,et al.  Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 α across the blood-brain barrier , 1996, Journal of Neuroimmunology.

[51]  S. Maier,et al.  Subdiaphragmatic vagotomy does not block intraperitoneal lipopolysaccharide-induced fever , 2000, Autonomic Neuroscience.

[52]  Y. Ando Transdermal Nicotine for Ulcerative Colitis , 1997, Annals of Internal Medicine.

[53]  Kevin J. Tracey,et al.  Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.

[54]  M. Sofroniew,et al.  Serum Proteins Bypass the Blood-Brain Fluid Barriers for Extracellular Entry to the Central Nervous System , 1993, Experimental Neurology.

[55]  P. Bennett,et al.  Autonomic Neuropathy in Rheumatoid Arthritis , 1965, Annals of the rheumatic diseases.

[56]  J. Licinio,et al.  Localization of interleukin 1 type I receptor mRNA in rat brain , 1994, Biological Psychiatry.

[57]  R G Newcombe,et al.  Transdermal nicotine for active ulcerative colitis. , 1994, The New England journal of medicine.

[58]  Steven F. Maier,et al.  Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication , 1995, Neuroscience Letters.

[59]  J. Blalock The immune system as a sensory organ. , 1984, Journal of immunology.

[60]  Yasuyoshi Watanabe,et al.  Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever , 1996, Brain Research.

[61]  W. Banks,et al.  Blood to brain transport of interleukin links the immune and central nervous systems. , 1991, Life sciences.

[62]  C. Saper,et al.  Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain , 1992, The Journal of comparative neurology.

[63]  M. Blennerhassett,et al.  Acetylcholine Metabolism in the Inflamed Rat Intestine , 1998, Experimental Neurology.

[64]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[65]  C. Kirkpatrick,et al.  Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. , 1998, Pharmacology & therapeutics.

[66]  Klaus Ley,et al.  Integration of inflammatory signals by rolling neutrophils , 2002, Immunological reviews.

[67]  M. Kluger,et al.  Effect of nicotine on the immune system: Possible regulation of immune responses by central and peripheral mechanisms , 1998, Psychoneuroendocrinology.

[68]  Kazuo Z. Sato,et al.  Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines , 1999, Neuroscience Letters.

[69]  T. C. Coleman,et al.  Inhibition of neutrophil and monocyte defensive functions by nicotine. , 1995, Journal of periodontology.

[70]  S. Maier,et al.  Vagal Paraganglia Bind Biotinylated Interleukin-1 Receptor Antagonist: A Possible Mechanism for Immune-to-Brain Communication , 1997, Brain Research Bulletin.

[71]  K. Tracey,et al.  Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway , 2002, The Journal of experimental medicine.

[72]  A. Walker,et al.  Cigarette smoking and ulcerative colitis. , 1983, The New England journal of medicine.

[73]  M. Oz,et al.  Vasopressin pressor hypersensitivity in vasodilatory septic shock. , 1997, Critical care medicine.

[74]  I. Wessler,et al.  Muscarinic control of histamine release from airways. Inhibitory M1-receptors in human bronchi but absence in rat trachea. , 2000, American journal of respiratory and critical care medicine.

[75]  S. Maier,et al.  Implications of immune-to-brain communication for sickness and pain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.